Rituximab maintenance therapy improves survival in patients with relapsed follicular lymphoma
Wednesday, February 11, 2009 - 05:08
in Health & Medicine
Patients with relapsed or refractory follicular lymphoma who continue on maintenance rituximab therapy after chemotherapy have better overall survival than patients who do not receive this treatment, according to a meta-analysis of randomised trials in the 10 February online issue of the Journal of the National Cancer Institute...